Semaglutide is a GLP-1 receptor agonist originally developed to treat type 2 diabetes — and later approved for weight loss under brand names like Ozempic and Wegovy. It works by mimicking a hormone that regulates blood sugar and appetite, making it highly effective for both weight management and metabolic health. Medicare Part D may cover…
